Apixaban Works Across Afib Risk Levels MedPage Today By Todd Neale, Senior Staff Writer, MedPage Today The novel anticoagulant apixaban reduces the risk of stroke and major bleeding among patients with atrial fibrillation, regardless of baseline risk, a secondary analysis of the ARISTOTLE trial showed. New Anti-Clotting Drug Bests Warfarin, Study SaysiVillage Entertainment
0 comments:
Post a Comment